Company intelligence / Profile preview
Janssen Pharmaceutical K.K.
Nagaizumicho, Shizuoka, Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
Janssen Pharmaceutical K.K. (Japan affiliate of Janssen/Johnson & Johnson) has a broad commercial portfolio and late-stage pipeline in oncology, immunology, neuroscience, pain, and infectious diseases, including multiple approved and globally commercialized therapies. Key highlights include significant marketed products, major clinical collaborations, and a robust development pipeline with several advanced stage and marketed candidates.[4][5]
- Therapeutic areas
- OncologyNeurologyInfectious DiseasesImmunology
- Modalities
- Small moleculeMonoclonal antibodyBiologicRecombinant proteinKinase inhibitor
- Industry
- Pharma
02
Drug pipeline
1 asset03
Partnerships
Nippon Shinyaku
Beyond the preview
Go deeper on Janssen Pharmaceutical K.K..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Janssen Pharmaceutical K.K..